ObsEva SA to present at the H.C Wainwright 22nd Annual Global Investment Virtual Conference, September 14-16, 2020

Rhea-AI Summary

ObsEva SA (NASDAQ: OBSV), a biopharmaceutical company focused on women's reproductive health, announced that CEO Ernest Loumaye will present at the H.C Wainwright 22nd Annual Global Investment Virtual Conference from September 14-16, 2020. His presentation is scheduled for September 16 at 12:00 p.m. ET. Investors can access the live presentation through the Events Calendar on ObsEva's website at www.ObsEva.com. The company is developing therapies for conditions like endometriosis and uterine fibroids.

 

Geneva, Switzerland and Boston, MA –  September 8, 2020 – ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health, today announced that CEO Ernest Loumaye will present an update on the Company and its pipeline at the H.C Wainwright 22^nd Annual Global Investment Virtual Conference taking place September 14-16, 2020.

Mr. Loumaye’s presentation will take place on Wednesday September 16 at 12:00 p.m. Eastern Time (ET).  A live presentation link will be available under “Events Calendar” in the investors section of ObsEva’s website at www.ObsEva.com

About ObsEva

ObsEva is a biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health and pregnancy. Through strategic in-licensing and disciplined drug development, ObsEva has established a late-stage clinical pipeline with development programs focused on treating endometriosis, uterine fibroids, preterm labor, and improving ET outcomes following IVF. ObsEva is listed on the Nasdaq Global Select Market and is trading under the ticker symbol "OBSV" and on the SIX Swiss Exchange where it is trading under the ticker symbol “OBSN”. For more information, please visit www.ObsEva.com.

For further information, please contact:

CEO Office contact
Shauna Dillon
Shauna.dillon@obseva.ch
+41 22 552 1550

Investor Contact
Mario Corso
Vice President, Investor Relations
mario.corso@obseva.com

+1 857 972 9347 Office
+1 781 366 5726 Mobile

 

 

 

Attachment

• Press Release in Pdf

FAQ

What is the date of ObsEva's presentation at the H.C Wainwright Conference?

ObsEva's CEO will present on September 16, 2020.

What time will the ObsEva presentation take place?

The presentation is scheduled for 12:00 p.m. Eastern Time.

Where can I watch the ObsEva presentation live?

The live presentation will be available on the Events Calendar at www.ObsEva.com.

What is ObsEva focusing on in its pipeline?

ObsEva is developing therapies for women's reproductive health, including conditions like endometriosis and uterine fibroids.

What is ObsEva's stock symbol?

ObsEva is listed on NASDAQ under the ticker symbol 'OBSV'.